TCL Archive Ford Asks NCAB for Scientific Basis For Regulation Of Tar and Nicotine Content Of Cigarettes By Dec. October 25, 1974
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months September 27, 2013